Mercator Medical S.A. (WSE:MRC)

Mercator Medical Balance Sheet

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	119.4	123.15	217.33	223.34	339.61	399.84
Short-Term Investments	79.26	126.96	109.53	198.46	195.7	147.32
Cash & Short-Term Investments	198.66	250.11	326.86	421.8	535.3	547.16
Cash Growth	-45.17%	-23.48%	-22.51%	-21.20%	-2.17%	3601.26%
Accounts Receivable	91.32	91.86	61.17	49.97	99.27	97.13
Other Receivables	17.78	23.76	42.51	19.54	25.32	19.28
Receivables	185.84	168.72	104.11	69.92	124.6	116.42
Inventory	212.56	214.65	153.09	204.67	253.36	429.6
Prepaid Expenses	0.64	0.49	0.52	0.45	0.56	0.43
Other Current Assets	0.71	0.7	0.66	0.72	0.35	1.92
Total Current Assets	598.4	634.67	585.24	697.56	914.17	1,096
Property, Plant & Equipment	325.11	310.79	251.66	281.96	334.65	183.41
Long-Term Investments	5.46	5.63	2.01	0.73	-	-
Other Intangible Assets	29.7	31.75	33.14	24.11	9.65	3.87
Long-Term Deferred Tax Assets	32.93	29.85	24.16	29.7	28.38	6.49
Other Long-Term Assets	10.14	10.78	2.96	4.05	1.68	0.02
Total Assets	1,002	1,043	965.23	1,083	1,289	1,289
Accounts Payable	55.22	77.29	53.49	35.8	62.41	100.58
Accrued Expenses	14.51	10.1	9.61	12.85	16.03	22.81
Short-Term Debt	0.07	0.05	0.15	0.21	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	0.69
Current Portion of Leases	2.75	1.44	0.85	0.72	1.31	1.54
Current Income Taxes Payable	0.57	2.4	4.24	0.03	24.61	89.42
Current Unearned Revenue	0.4	0.2	0.63	3.1	27.72	23.56
Other Current Liabilities	0.88	5.4	9.51	7.25	0.97	1.31
Total Current Liabilities	74.4	96.87	78.47	59.96	133.05	239.89
Long-Term Leases	20.99	3.07	4.41	2.46	3.52	2.02
Long-Term Unearned Revenue	-	-	0.15	0.16	0.16	0.17
Long-Term Deferred Tax Liabilities	12.43	15.78	20.87	8.54	4.35	2.96
Other Long-Term Liabilities	2.56	2.55	1.61	2.73	2.23	1.13
Total Liabilities	110.38	118.28	105.52	73.85	143.32	246.17
Common Stock	9.77	9.77	10.65	10.65	10.65	10.6
Additional Paid-In Capital	30.74	30.74	30.74	57.84	57.84	57.14
Retained Earnings	907.97	895.17	854.82	888.22	1,079	963.76
Comprehensive Income & Other	-54.09	-7.36	-34.12	52.02	-3.28	8.45
Total Common Equity	894.39	928.32	862.09	1,009	1,144	1,040
Minority Interest	-3.03	-3.16	-2.38	0.49	1.36	3.18
Shareholders' Equity	891.36	925.16	859.71	1,009	1,145	1,043
Total Liabilities & Equity	1,002	1,043	965.23	1,083	1,289	1,289
Total Debt	23.81	4.56	5.41	3.39	4.83	4.25
Net Cash (Debt)	174.85	245.55	321.45	418.41	530.47	542.91
Net Cash Growth	-51.05%	-23.61%	-23.17%	-21.12%	-2.29%	-
Net Cash Per Share	18.77	26.15	33.54	42.82	52.41	51.56
Filing Date Shares Outstanding	9.77	9.77	9.77	10.65	10.65	10.41
Total Common Shares Outstanding	9.77	9.77	9.42	10.65	10.65	10.41
Working Capital	524	537.8	506.76	637.6	781.12	855.63
Book Value Per Share	91.54	95.01	91.54	94.74	107.43	99.92
Tangible Book Value	864.68	896.57	828.95	984.62	1,134	1,036
Tangible Book Value Per Share	88.50	91.76	88.02	92.48	106.53	99.55
Land	-	45.99	41.8	47.24	51.94	8.78
Buildings	-	118.6	100.87	110.96	79.99	74.45
Machinery	-	274.18	223.41	201.74	172.21	170.27
Construction In Progress	-	5.68	1.07	32.75	115.12	4.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.